Indication
Diabetic Macular Oedema
2 clinical trials
2 products
Product
IBE-814Clinical trial
RIPPLE-1: Evaluation of Safety and Efficacy of the IBE-814 Intravitreal Implant in Patients With Diabetic Macular Oedema and Macular Oedema Due to Retinal Vein OcclusionStatus: Active (not recruiting), Estimated PCD: 2024-04-30
Product
RanibizumabClinical trial
Noctura400 Treatment for Diabetic Retinopathy: Pilot Study to Demonstrate and Evaluate the Care Pathway for National Health Service (NHS) AdoptionStatus: Terminated, Estimated PCD: 2023-08-01